When Should You Buy Bodal Chemicals Limited - Simply Wall St

BODALCHEM   69.31  0.12  0.17%   
Under 62% of Bodal Chemicals' investor base is looking to short. The analysis of overall sentiment of trading Bodal Chemicals Limited stock suggests that many investors are alarmed at this time. Bodal Chemicals' investing sentiment shows overall attitude of investors towards Bodal Chemicals Limited.
  
When Should You Buy Bodal Chemicals Limited Simply Wall St

Read at news.google.com
Google News at Macroaxis
  

Bodal Chemicals Fundamental Analysis

We analyze Bodal Chemicals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bodal Chemicals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bodal Chemicals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Retained Earnings

Retained Earnings Comparative Analysis

Bodal Chemicals is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

Bodal Chemicals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bodal Chemicals stock to make a market-neutral strategy. Peer analysis of Bodal Chemicals could also be used in its relative valuation, which is a method of valuing Bodal Chemicals by comparing valuation metrics with similar companies.

Complementary Tools for Bodal Stock analysis

When running Bodal Chemicals' price analysis, check to measure Bodal Chemicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bodal Chemicals is operating at the current time. Most of Bodal Chemicals' value examination focuses on studying past and present price action to predict the probability of Bodal Chemicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bodal Chemicals' price. Additionally, you may evaluate how the addition of Bodal Chemicals to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.